Relationship between neutralizing and opsonizing monoclonal antibodies against foot-and-mouth disease virus

Relationship between neutralizing and opsonizing monoclonal antibodies against foot-and-mouth disease virus

Previous studies demonstrated that polyclonal antibodies against foot-and-mouth disease virus (FMDV) generated by vaccination can mediate immune functions not only through virus neutralization but also through promoting virus uptake by macrophages and dendritic cells that are otherwise resistant to...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Artur Summerfield, Heidi Gerber, Rebeka Schmitt, Matthias Liniger, Santina Grazioli, Emiliana Brocchi
Formato:	Artigo
Idioma:	English
Publicado em:	Frontiers Media S.A. 2022-10-01
coleção:	Frontiers in Veterinary Science
Assuntos:	FMDV opsonization antibodies monoclonal antibody Fc gamma receptors
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fvets.2022.1033276/full

Registros relacionados

Monoclonal Antibodies as Tools to Combat Fungal Infections
por: Sebastian Ulrich, et al.
Publicado em: (2020-02-01)

Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of Treponema pallidum BamA (TP0326)
por: Mary R. Ferguson, et al.
Publicado em: (2023-08-01)

Protective Capacity of Monoclonal Antibodies against Acinetobacter baumannii K9 Capsular Polysaccharide
por: Anna Karatovskaya, et al.
Publicado em: (2023-02-01)

Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation
por: Shashi Kant Kumar, et al.
Publicado em: (2015-01-01)

Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
por: Jessica Swanson, et al.
Publicado em: (2021-04-01)

Characterization and protective activity of monoclonal antibodies directed against Fe (3+) ABC transporter substrate-binding protein of Glaesserella parasuis
por: Kexin Zhu, et al.
Publicado em: (2021-07-01)

Development of a serotype colloidal gold strip using monoclonal antibody for rapid detection type Asia1 foot-and-mouth disease
por: Gao Shan-dian, et al.
Publicado em: (2011-09-01)

Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality
por: Nicolas Aubrey, et al.
Publicado em: (2022-08-01)

Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer
por: Marjorie A. Shapiro
Publicado em: (2024-04-01)

Production and characterization of monoclonal antibodies anti fragment Fc of bovine IgG
por: Tânia Regina Penha, et al.
Publicado em: (2010-02-01)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
por: Ahmed M. Khalil, et al.
Publicado em: (2023-07-01)

Combining Multiple Assays Improves Detection and Serotyping of Foot-and-Mouth Disease Virus. A Practical Example with Field Samples from East Africa
por: Efrem Alessandro Foglia, et al.
Publicado em: (2021-08-01)

Development and Validation of Serotype-Specific Blocking ELISA for the Detection of Anti-FMDV O/A/Asia1/SAT2 Antibodies
por: Mohammad A. Kashem, et al.
Publicado em: (2024-09-01)

Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
por: Sergei S. Biryukov, et al.
Publicado em: (2023-05-01)

Large-scale production of monoclonal antibodies in suspension culture /
por: 271860 Backer, M. P., et al.

Monoclonal antibodies : the second generation /
por: 186276 Zola, Heddy
Publicado em: (1995)

Functional and in silico Characterization of Neutralizing Interactions Between Antibodies and the Foot-and-Mouth Disease Virus Immunodominant Antigenic Site
por: Ruben Marrero Diaz de Villegas, et al.
Publicado em: (2021-05-01)

Monoclonal antibodies /
por: Peter, J. H., et al.
Publicado em: (1992)

OPSONIZING PROPERTIES OF A COMMERCIAL ANTISTAPHYLOCOCCAL IMMUNOGLOBULIN
por: S. V. Slobodchikova, et al.
Publicado em: (2014-07-01)

Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
por: Fabiola Vacca, et al.
Publicado em: (2022-08-01)

Serotypes With Low Invasive Potential Are Associated With an Impaired Antibody Response in Invasive Pneumococcal Disease
por: Nils Littorin, et al.
Publicado em: (2018-11-01)

Monoclonal antibodies : principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology /
por: 250151 Goding, James W.
Publicado em: (1996)

West Nile virus: characterization and diagnostic applications of monoclonal antibodies
por: Lelli Davide, et al.
Publicado em: (2012-04-01)

Broadening anticancer spectrum by preprocessing and treatment of T- lymphocytes expressed FcγRI and monoclonal antibodies for refractory cancers
por: Lei Tang, et al.
Publicado em: (2024-06-01)

Mycobacterium abscessus Opsonization Allows an Escape from the Defensin Bactericidal Action in Drosophila
por: Hamadoun Touré, et al.
Publicado em: (2023-08-01)

Monoclonal antibodies against Mycobacterium tuberculosis, detecting the antigen in urine of the pulmonary tuberculosis patients
por: A. V. Onyan, et al.
Publicado em: (2016-02-01)

Current trends in monoclonal antibody development and manufacturing /
por: Shire, Steven J.
Publicado em: (2010)

Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy
por: Maira Zorzan, et al.
Publicado em: (2023-08-01)

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
por: Alberto L. Horenstein, et al.
Publicado em: (2025-02-01)

Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus
por: Zoltán Bánki, et al.
Publicado em: (2019-02-01)

Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play
por: Jennifer Lambour, et al.
Publicado em: (2016-01-01)

Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies
por: Brian A. Baldo
Publicado em: (2022-02-01)

Monoclonal antibodies in immunoscintigraphy /
por: Chatal, Jean-Francois
Publicado em: (1989)

Prediction of the pharmacokinetics, pharmacodynamics and efficacy of a monoclonal antibody, using a physiologically based pharmacokinetic FcRn model.
por: Manoranjenni eChetty, et al.
Publicado em: (2015-01-01)

Monoclonal antibodies : methods and protocols /
por: Albitar, Maher
Publicado em: (2007)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
por: Liming Liu
Publicado em: (2017-04-01)

Identification and characterisation of candidate monoclonal antibody Ebolavirus therapeutics
por: Donnellan, FR
Publicado em: (2021)

Opsonization Inveigles Macrophages Engulfing Carrier‐Free Bilirubin/JPH203 Nanoparticles to Suppress Inflammation for Osteoarthritis Therapy
por: Huirong Huang, et al.
Publicado em: (2024-06-01)

Large-scale preparation of purified monoclonal antibody from cell culture supernatant: A case study with a monoclonal antibody to Zeta globin chain
por: Matawee Pongpaiboon, et al.
Publicado em: (2018-05-01)

Monoclonal antibodies : a manual of techniques /
por: 186276 Zola, Heddy
Publicado em: (1987)